Cargando…
Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
Functional gastrointestinal disorders (FGIDs) have been re-named as disorders of gut-brain interactions. These conditions are not only common in clinical practice, but also in the community. In reference to the Rome IV criteria, the most common FGIDs, include functional dyspepsia (FD) and irritable...
Autores principales: | Singh, Rajan, Zogg, Hannah, Ghoshal, Uday C, Ro, Seungil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822166/ https://www.ncbi.nlm.nih.gov/pubmed/35145413 http://dx.doi.org/10.3389/fphar.2022.808195 |
Ejemplares similares
-
Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders
por: Singh, Rajan, et al.
Publicado: (2021) -
Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology
por: Wei, Lai, et al.
Publicado: (2021) -
Role of microRNAs in Disorders of Gut–Brain Interactions: Clinical Insights and Therapeutic Alternatives
por: Singh, Rajan, et al.
Publicado: (2021) -
Current Advances in RNA Therapeutics for Human Diseases
por: Zogg, Hannah, et al.
Publicado: (2022) -
miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes
por: Zogg, Hannah, et al.
Publicado: (2023)